Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.30 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.30 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2525977 | 1.00 | CA1 (0.39) | CA1CA2CA7CA9SMPD1 | |
| Choline SCHEMBL16267506 | 0.87 | MEN1 (0.32) | CA1CA2CA7 | |
| SCHEMBL8722298 | 0.86 | CA1 (0.37) | CA1CA2CA7CA9 | |
| SCHEMBL28412357 | 0.84 | CA1 (0.38) | CA1CA2CA7CA9 | |
| SCHEMBL958656 | 0.84 | LPAR3 (0.40) | CA1CA2CA7CA9LPAR2 | |
| SCHEMBL8015659 | 0.83 | CA1 (0.35) | CA1CA2CA7CA9 | |
| SCHEMBL7833013 | 0.83 | CA1 (0.33) | CA1CA2CA7CA9 | |
| SCHEMBL958655 | 0.83 | CA1 (0.37) | CA1CA2CA7CA9 | |
| SCHEMBL15290149 | 0.81 | CA1 (0.36) | CA1CA2CA7CA9SMPD1 | |
| SCHEMBL28066491 | 0.81 | CA1 (0.36) | CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130197038-A1 | Compositions And Methods For Neovascularization | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-08-01 | — | — | US | claimed |
| US-20210315244-A1 | COMPOUNDS THAT MODULATE GPR92 RECEPTOR ACTIVITY AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS, INCORPORATED (US) | 2021-10-14 | — | — | US | disclosed |
| EP-3846640-A1 | COMPOUNDS THAT MODULATE GPR92 RECEPTOR ACTIVITY AND PET FOOD PRODUCTS CONTAINING THE SAME | Mars Incorporated (US) | 2021-07-14 | — | — | EP | disclosed |
| US-10071110-B2 | Phosphonate compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-09-11 | — | — | US | disclosed |
| US-20170239279-A1 | PHOSPHONATE COMPOUNDS | UNIV CALIFORNIA (US) | 2017-08-24 | — | — | US | disclosed |
| US-9649321-B2 | Phosphonate compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-05-16 | — | — | US | disclosed |
| US-9446031-B2 | Compositions and methods for neovascularization | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2016-09-20 | — | — | US | disclosed |
| US-20160067268-A1 | PHOSPHONATE COMPOUNDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-03-10 | — | — | US | disclosed |
| US-9206208-B2 | Phosphonate compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-12-08 | — | — | US | disclosed |
| US-20150051174-A1 | Phosphonate Compounds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-02-19 | — | — | US | disclosed |
| EP-1233770-A4 | PHOSPHONATE COMPOUNDS | UNIV CALIFORNIA AT SAN DIEGO (US) | 2003-04-16 | — | — | EP | disclosed |
| EP-1300426-A1 | (Meth)acrylic acid type polymer and unsaturated polyalkylene glycol type copolymer, and methods for production thereof | Nippon Shokubai Co., Ltd. (JP) | 2003-04-09 | — | — | EP | disclosed |
| US-6451952-B2 | POLYMERIZING ALLYL ETHER MONOMER IN PRESENCE OF HALOALKYL DIOXOLANE COMPOUND (BY-PRODUCT, IMPURITY); ANTISCALING AGENT WITH IMPROVED GELATION INHIBITION | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-09-17 | — | — | US | disclosed |
| EP-1233770-A2 | PHOSPHONATE COMPOUNDS | The Regents of The University of California at San Diego (US) | 2002-08-28 | — | — | EP | disclosed |
| US-20020049147-A1 | Novel water-soluble copolymer and its production process and use | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-04-25 | — | — | US | disclosed |
| EP-1182217-A2 | Novel water-soluble copolymer and its production process and use | Nippon Shokubai Co., Ltd. (JP) | 2002-02-27 | — | — | EP | disclosed |
| US-20020016430-A1 | Production process for allyl ether-based polymer | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-02-07 | — | — | US | disclosed |
| EP-1158009-A2 | Production process for allyl ether-based polymer | Nippon Shokubai Co., Ltd. (JP) | 2001-11-28 | — | — | EP | disclosed |
| WO-2001039724-A2 | PHOSPHONATE COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) | 2001-06-07 | — | — | WO | disclosed |
| US-4500693-A | OF (METH-)ACRYLIC ACID (OR SALT THEREOF) AND ALLYL ETHERSULFONATE | NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JP) | 1985-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051174-A1 | Phosphonate Compounds | PHPT1, PHOSPHO1, PIK3CA | CA1 4092/4885CA2 3473/4885CA7 3176/4885 |
| US-10071110-B2 | Phosphonate compounds | PHPT1, PHOSPHO1, PIK3CA | CA1 4092/4885CA2 3473/4885CA7 3176/4885 |
| US-20170239279-A1 | PHOSPHONATE COMPOUNDS | PHPT1, PHOSPHO1, PIK3CA | CA1 4092/4885CA2 3473/4885CA7 3176/4885 |
| US-20160067268-A1 | PHOSPHONATE COMPOUNDS | PHPT1, PHOSPHO1, PIK3CA | CA1 4092/4885CA2 3473/4885CA7 3176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.